This program provides infusion of non-dilutive catalytic capital of up to INR 4 crore (~USD 600,000) along with seed venture funding and business-building support both from Unitus and our healthcare partners.
Up to INR 1.75 crore ($250K) of non-dilutive capital to fund immediate pre-commercialisation business progress
Up to INR 3.5 crore ($500K) of seed venture capital on achievement of mutually defined milestones
Support from Unitus and its partners to prepare for growth and raise scale-up capital
Areas of Interest
Key Selection Criteria
Pfizer is one of the world’s premier innovative biopharmaceutical companies that discovers, develops, manufactures and markets prescription human and veterinary medicines, and consumer healthcare products.
Dr. Michael J. Free, OBE, Ph. D., is a Special Advisor, Healthcare to Unitus Seed Fund. He also serves as PATH’s senior advisor emeritus, and as a senior advisor to major foundations and leading NGO organizations including Village Reach, Intellectual Ventures’ Global Good, and the Lemelson Foundation.
We have several interesting ways you can connect with us –
You can always apply for seed funding, and if you the right fit, we would love to invest and partner with you.
Keep an eye out for our annual StartHealth Competition. For details and application criteria, subscribe to our newsletter.